Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Index 

Index
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 September 2021

Abuse
alcohol. See[link]
child
depression and, [link], [link]
neuroendocrine changes, [link]
suicidal behavior and, [link]
drug. See[link]
physical, suicidal behavior and, [link]
sexual. See[link]
Access
to mental health services
cultural barriers, [link]
in schools, [link], [link], [link]t, [link]t
survey findings, [link], [link], [link]
system barriers, [link]
to substance abuse treatment
barriers, [link]
for step-down services, [link]
system change considerations, [link]
Acute stress disorder, [link]
Addiction. See[link]
ADHD. See[link]
Adolescence. See also[link]
age range, [link]
biological features, [link]
brain development during, [link] [link], [link]f, [link]
definition, [link] [link]
environmental context, [link]
hormonal changes, [link] , [link]
mental health problems during. See[link]; specific disorders
substance use during. See[link]; [link]
weight loss interventions during, [link]
Adolescent Suicide Awareness Program, [link], [link]t
Adolescent Transitions Program, [link]
Adrenal hormones, and adolescent behavior, [link] [link]
Adventure programs, [link], [link]t
Affective disorders. See[link]
African Americans
access to mental health services, [link]
depression, [link], [link]
substance use, [link]
suicide rate, [link]
After-school programs, for positive youth development, [link], [link]
Aggressive behavior. See also[link]
and suicide, [link]
Agoraphobia, [link], [link]
Alaskan Natives, suicide rate, [link]
Alcohol dehydrogenase, [link]
Alcohol use and abuse
and alcohol dependence as adult, [link]
anxiety and, [link]
clinical aspects, [link], [link]t
cocaine and, [link]
in college setting, [link]
consequences, [link]
detoxification, [link]
in “gateway” hypothesis, [link]
general description, [link]
genetics, [link]
prevalence, [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
problematic, [link], [link]t
school professional findings, [link], [link]t
and use of emergency department, [link]
withdrawal, [link], [link]t
zero-tolerance policies, [link]
Alcohol use disorders (AUDs)
comorbidity, [link]
etiology, [link]
issues in determining, [link]
pharmacotherapy, [link]
prevalence, [link]
Allostasis, brain reward center, in substance use disorders, [link]
Alprazolam, for panic disorder, [link]
Amenorrhea, in anorexia nervosa, [link], [link]
American Academy of Pediatrics, eating disorders treatment guidelines, [link]
American Foundation for Suicide Prevention, [link], [link]t, [link]
American Indians, suicide rate, [link]
American Psychiatric Association, eating disorders treatment guidelines, [link]
American Psychological Association, standards for evidence-based mental health services, [link]
Amphetamine abuse. See also[link]
in adolescence, [link]
schizophrenia and, [link]
Amygdala
activating factors, [link]
in anxiety disorders, [link]
developmental changes, [link] [link]
extended, in drug addiction, [link]
Anandamide, [link]
Angel dust, [link]
Animal models, substance use disorders, [link], [link]f, [link]f
Annenberg Public Policy Center
primary care physician survey, [link]
school mental health professionals survey, [link]
Annie E. Casey Foundation Blue Sky Project, [link]
Anorexia nervosa. See also[link]
age differences, [link]
binge eating/purging subtype, [link], [link]t
combination therapy, [link]
comorbidity, [link], [link], [link]
diagnostic criteria, [link], [link]t, [link], [link]
diagnostic migration, [link], [link]
dieting and, [link], [link]
DSM-IV criteria, [link], [link]t, [link]
epidemiology, [link], [link]t, [link]t, [link]
etiology, [link]
full-syndrome, [link], [link]
genetics, [link]
inpatient treatment, [link]
medical complications, [link], [link]t, [link]
osteopenia in, [link], [link]
outcome, [link], [link]
outpatient treatment, [link]
partial-syndrome, [link]
pharmacotherapy, [link], [link]
prevalence, [link], [link], [link]t, [link]t
prevention programs, [link]
combined, [link]
in high-risk populations and settings, [link]
research agenda, [link]
targeted, [link]
universal, [link]
psychosocial therapy, [link]
evaluation, [link]
randomized controlled trials, [link]
relapse prevention, [link]
refeeding in, [link]
relapse prevention, [link], [link], [link]
restricting subtype, [link], [link]t
risk factors, [link], [link]t, [link]
biological, [link]
eating and weight-related, [link]
environmental, [link]
general, [link]
genetic, [link]
individual, [link]
weight restoration, [link]
Antepartum depression, [link]
Anticonvulsants, in schizophrenia, [link]
Antidepressants. See also specific drugs
for anorexia nervosa, [link], [link]
for bipolar disorder, [link]
for bulimia nervosa, [link], [link]
for generalized anxiety disorder, [link], [link]
heterocyclic, for major depressive disorder, [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link]
combination and augmentation therapy, [link], [link], [link]
public health advisory on, [link]
in schizophrenia, [link]
selective serotonin and noradrenaline reuptake inhibitor, for major depressive disorder, [link]
selective serotonin reuptake inhibitor. See[link]
suicidal ideation and, [link] [link], [link], [link], [link]
for suicide attempters, [link], [link]
tricyclic
for generalized anxiety disorder, [link], [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link]t
for panic disorder, [link]
Antipsychotics. See also specific drugs
atypical
for anorexia nervosa, [link]
for bipolar disorder
in adults, [link]
with mood stabilizers, [link]
for major depressive disorder, [link]
for schizophrenia
acute treatment, [link], [link]t, [link]
adjuncts to, [link]
maintenance treatment, [link], [link]t
side effects, [link]
Anxiety disorders, [link]
age differences, [link]
autonomic nervous system abnormalities, [link], [link]
biological correlates, [link]
biological features, [link]
brain developmental changes, [link]
brain imaging, [link]
cognitive-behavioral therapy, [link]
developmental considerations, [link]
education and skill-building, [link]
exposure exercises, [link]
history and rationale, [link]
maintenance of gains, [link]
mechanisms, [link]
with pharmacotherapy, [link]
recommendations, [link]t
research agenda, [link]
cognitive factors, [link], [link], [link]
community factors, [link]
comorbidity, [link], [link]t
alcohol use disorders, [link]
bipolar disorder, [link]
depression, [link], [link], [link], [link]
eating disorders, [link], [link], [link]
substance use disorder, [link]
criminal behavior and, [link]
defining, [link], [link]
descriptions, [link], [link]
disability requirement, [link]
electroencephalography, [link]
emotional processing theory, [link]
environmental factors, [link]
etiology and maintenance theories, [link]
exposure therapy, mechanisms, [link], [link]
family factors, [link]
fear structures
cognitive-behavioral therapy and, [link]
emotional processing theory and, [link]
gang affiliation and, [link]
gender differences, [link]
generalized
in children and adolescents, [link]
comorbidity, [link], [link]t
description, [link]
genetics, [link], [link]t
signs and symptoms, [link]t
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
genetics, [link], [link]t, [link]
HPA axis in, [link]
immunology, [link]
learning theories, [link]
neurobiology, [link], [link]
neurochemistry, [link]
neuroticism and, [link]
obsessive-compulsive disorder as. See[link]
onset and course, [link]
panic disorder as. See[link]
peer factors, [link]
pharmacotherapy
with cognitive-behavioral therapy, [link]
rationale, [link]
recommendations, [link]t
research agenda, [link]
post-traumatic stress disorder as. See[link]
prevalence, [link]
prevention, [link]
early detection and screening, [link]
issues, [link]
model programs, [link]
outcome evaluation, [link]
research agenda, [link]
risk factors and protective factors, [link], [link]t
theoretical models, [link]
prevention programs, [link]
indicated, [link]
selective, [link]
universal, [link]
primary care physician findings, [link], [link]t, [link], [link], [link], [link]t
rating scales, [link]
relapse prevention, [link]
research agenda, [link]
risk factors, [link], [link]t
school factors, [link]
school professional findings, [link], [link]t
signs and symptoms, [link]t
smoking and, [link]
social. See[link]
social support and, [link]
substance abuse and, [link], [link]
subsyndromal anxiety symptoms versus, [link], [link]
suicidal behavior and, [link]
threat bias in
attentional, [link]
interpretative, [link]
treatment, [link]
acute, [link], [link]t
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
outcome summary, [link]t
research agenda, [link]
Anxiety Disorders Interview Schedule for Children, [link]
Anxiety sensitivity, [link]
Applied Suicide Intervention Skills Training (ASIST), [link], [link]t, [link]
Arnarson and Craighead program for prevention of depression, [link]
Asian Americans, suicide rate, [link]
Association studies, in schizophrenia, [link]
Asthma, depression and, [link]
Attachment
as outcome of positive youth development, [link]
security in, depression and, [link]
styles
anorexia nervosa and, [link]
anxiety disorders and, [link]
Attachment-based family therapy, for major depressive disorder, [link]
Attention deficit, in children of schizophrenic parents, [link], [link]
Attention-deficit/hyperactivity disorder, comorbidity
alcohol use disorder, [link]
bipolar disorder, [link]
depression, [link], [link]
substance use disorder, [link]
Attentional threat bias, in anxiety disorders, [link]
Attributional style, pessimistic
suicidal behavior and, [link]
and vulnerability to depression, [link]
Attributions, stigma and, [link]
Australia, depression prevention programs, [link]
Automobile accidents, alcohol-related, [link]
Autonomic nervous system abnormalities, in anxiety disorders, [link], [link]
Ballet dancers, anorexia nervosa in, [link], [link]
Basal ganglia, and motor dysfunction in schizophrenia, [link]
Beardslee program for prevention of depression, [link]
A Beautiful Mind, [link]
Behavior genetic theory of substance abuse, [link]
Behavioral competence, as outcome of positive youth development, [link]
Behavioral inhibition
and anxiety disorders, [link]
and depression, [link]
selective prevention intervention for, [link]
Behavioral managed care, [link]
Behavioral problems, premorbid, in schizophrenia, [link], [link], [link]t, [link], [link], [link]
Behavioral therapy. See also[link]
dialectical, for suicidal behavior, [link]t, [link]
for major depressive disorder, [link]
for selective mutism, [link]t, [link]
for separation anxiety disorder, [link]
for substance use disorders, [link]
for suicidal behavior, [link]
Belief in future, as outcome of positive youth development, [link]
Benzodiazepines
for generalized anxiety disorder, [link], [link]
for panic disorder, [link], [link]
for phobia, [link]
in schizophrenia, [link]
for separation anxiety disorder, [link]
Bibliotherapy, for subsyndromal depression, [link]
Big Brothers and Big Sisters, [link]t
Binge drinking, [link]f, [link]
Binge eating
in adolescents, [link]
in anorexia nervosa, [link], [link]t
in bulimia nervosa, [link]
Binge eating disorder, [link], [link]
Biological factors. See also[link]
in anorexia nervosa, [link]
in anxiety disorders, [link]
in positive youth development, [link]
in suicidal behavior, [link]
Bipolar disorder
age of onset, [link], [link]
brain abnormalities, [link]
classic (type I), [link]
community attitudes toward, [link], [link]t
comorbidity, [link], [link]
diagnosis, [link]
epidemiology, [link], [link]
family history and, [link]
genetics, [link], [link]t
hypomania in (type II), [link]
hypothalamic-pituitary-adrenal axis hyperactivity, [link]
mania in
diagnostic criteria, [link]
mixed, [link]
not otherwise specified, [link]
pharmacotherapy
in adolescents, [link], [link]t
in adults, [link]
combination therapy, [link]
maintenance therapy, [link]
prepubertal, versus adolescent-onset, [link]
prevention research agenda, [link], [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
psychosocial therapy, [link]
rates, [link], [link]t, [link]t
research agenda, [link]
risk factors, [link]
substance abuse and, [link], [link]
suicidal behavior and, [link]
treatment research agenda, [link]
Birth cohort studies, in schizophrenia, [link], [link], [link]t
Blood alcohol level (BAL), [link]
Blood phobia, [link]
Blue Sky Project, [link]
Body dissatisfaction
anorexia nervosa and, [link]
bulimia nervosa and, [link]
Body fat, fear of, as criterion for anorexia nervosa, [link]
Body mass index
anorexia nervosa and, [link]
bulimia nervosa and, [link]
Bonding, as outcome of positive youth development, [link]
Bone mineral density, in anorexia nervosa, [link]
Borderline personality disorder, plus suicidal behavior, dialectical behavioral therapy for, [link]
Brain. See also[link]
abnormalities
in anxiety disorders, [link]
in children of schizophrenic parents, [link]
in mood disorders, [link]
violence exposure and, [link]
circuitry
developmental shifts, [link] [link]
in schizophrenia, [link]
development
during adolescence, [link] [link], [link]f, [link]
myelinization, [link] [link], [link]f
synaptic pruning, [link] [link], [link]f, [link]
executive inhibitory circuitry defects, in substance use disorders, [link]
imaging
in anxiety disorders, [link]
in mood disorders, [link]
in schizophrenia, [link]
in substance use disorders, [link]
reward center dysregulation, [link], [link]
allostasis and, [link]
animal models, [link], [link]f, [link]f
imaging studies, [link]
pharmacotherapy for, [link]
volume
developmental changes, [link] [link], [link]f, [link]
in schizophrenia, [link]
Brief dynamic therapy, for major depressive disorder, [link]
Brief interventions, for substance use, [link]
Brief strategic family therapy, for substance use disorders, [link]
Bulimia nervosa. See also[link]
combination therapy, [link]
comorbidity, [link], [link]
diagnostic criteria, [link], [link]t, [link]
dieting and, [link], [link]
DSM-IV criteria, [link], [link]t
epidemiology, [link], [link]t, [link]t, [link]
etiology, [link]
full-syndrome, [link]
genetics, [link]
medical complications, [link]t, [link], [link]
outcome, [link], [link]
partial-syndrome, [link]
pharmacotherapy, [link], [link]
prevalence, [link], [link], [link], [link]t, [link]t
prevention programs, [link]
combined, [link]
in high-risk populations and settings, [link]
research agenda, [link]
targeted, [link]
universal, [link]
psychosocial therapy, [link], [link]
relapse prevention, [link], [link], [link]
risk factors, [link], [link]
Bullying
school professional findings, [link], [link]t
suicidal behavior and, [link]
Buprenorphine, for opioid addiction, [link], [link]
Bupropion
for ADHD plus substance use disorder, [link]
for major depressive disorder, [link]
for smoking cessation, [link]
Buspirone, for generalized anxiety disorder, [link], [link]
Calcium supplementation, in anorexia nervosa, [link]
California, reform initiatives on delivery of evidence-based practices, [link]
Caloric requirements, [link]
Cannabis. See[link]
Carbamazepine
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
for post-traumatic stress disorder, [link]
Cardiovascular system
in anxiety disorders, [link], [link]
in eating disorders, [link]t
Caring School Community, [link]t
CASASTART (Striving Together to Achieve Rewarding Tomorrows), [link]
Case identification, in mental health disorders, [link], [link]
CASEL (2003), [link]t
Catatonic features, depression with, [link]
Catchment approach, for prevention of substance abuse, [link]
Catechol-O-methyl transferase (COMT), as schizophrenia susceptibility gene, [link], [link]
CBT. See[link]
Center for Mental Health Services System of Care, [link]
Center for Prevention Research, [link]
Central intake unit, for substance abuse treatment, [link]
Cerebellum, developmental changes, [link] [link]
Change
consensual theory of, in positive youth development field, [link]
organizational readiness, [link]
Character strengths, [link], [link]
Chemical dependency. See[link]
Chemical transmission
in anxiety disorders, [link]
in drug addiction, [link]
Child abuse
depression and, [link], [link]
neuroendocrine changes, [link]
suicidal behavior and, [link]
Child and Adolescent Service System Program (CASSP), [link]
Child and Adolescent Trauma Screen (CATS), [link]
Child Behavior Checklist (CBCL), [link]
Child PTSD Symptom Scale (CPSS), [link]
Child Trends, [link], [link]t
Child welfare system, substance abuse identification, [link]
Childhood Anxiety Sensitivity Index (CASI), [link], [link]
Children. See also[link]
abuse of. See[link]
bipolar disorder in, versus adolescent-onset, [link]
generalized anxiety disorder in, [link]
major depressive disorder in
versus adolescent-onset, [link], [link]
antidepressants for, [link]
psychosocial therapy, [link]
obsessive-compulsive disorder in, [link]
panic disorder in, [link]
phobia in, [link]
post-traumatic stress disorder in, [link]
at risk for schizophrenia, longitudinal studies, [link], [link], [link], [link]t, [link]
schizophrenia in, event-related potentials in, [link], [link]t
social anxiety disorder in, [link]
weight loss interventions for, [link]
CHRNA7, as schizophrenia susceptibility gene, [link]
Cigarette smoking. See[link]
Citalopram, for major depressive disorder, [link], [link], [link]t
Clarke program for prevention of depression, [link]
Classical conditioning
in anxiety disorders, [link]
in substance use disorders, [link]
Climate, organizational, [link]
Clinic-community intervention model for treatment development, [link]
Clomipramine
for obsessive-compulsive disorder, [link], [link]
for panic disorder, [link]
Clonazepam, for panic disorder, [link], [link]
Clonidine, for post-traumatic stress disorder, [link]
Clozapine
for bipolar disorder, [link]
for psychotic disorder and suicidal behavior, [link]
for schizophrenia, [link]t, [link]t, [link]t, [link]
for suicide attempters, [link]
Club drugs, [link]
Cocaine use, [link], [link]t
alcohol and, [link]
clinical aspects, [link], [link]t
genetics, [link]
medical complications, [link]
treatment, [link]
withdrawal, [link], [link]t
Cognitive-behavioral analysis system of psychotherapy, for major depressive disorder, [link]
Cognitive-behavioral therapy
for anorexia nervosa, [link]
for anxiety disorders
developmental considerations, [link]
education and skill-building, [link]
exposure exercises, [link]
history and rationale, [link]
maintenance of gains, [link]
mechanisms, [link]
with pharmacotherapy, [link]
recommendations, [link]t
research agenda, [link]
for bipolar disorder, [link]
for bulimia nervosa, [link], [link], [link]
for eating disorders, [link], [link]
for generalized anxiety disorder, [link]t, [link], [link]
for major depressive disorder
in adults, [link], [link]
in children and adolescents, [link], [link]t, [link]f, [link]t
in Latino youth, [link]
with pharmacotherapy, [link]
prevention programs, [link], [link]
symptomatic community samples, [link]
for obsessive-compulsive disorder, [link]t, [link], [link]
for panic disorder, [link]t, [link], [link], [link]
for phobia, [link]t, [link]
for post-traumatic stress disorder, [link]t, [link], [link], [link], [link]
for schizophrenia, [link], [link]
for separation anxiety disorder, [link]t, [link]
for social anxiety disorder, [link]t, [link]
for substance use disorders, [link]
for subsyndromal depression, [link]
for suicidal adults, [link]
for suicidal youth, [link], [link], [link]t, [link]
Cognitive competence, as outcome of positive youth development, [link]
Cognitive diathesis-stress model, of depression, [link]
Cognitive factors, in anxiety disorders, [link], [link], [link]
Cognitive impairment
in marijuana use, [link]
in schizophrenia, [link], [link], [link]f, [link], [link]f, [link], [link]
Cognitive remediation therapy, for schizophrenia, [link]
Colleges
drinking issues, [link]
suicide prevention programs, [link], [link], [link]t, [link], [link]
Columbia TeenScreen Program (CTSP), [link], [link]t, [link]
Combined drug and psychosocial treatments
anxiety disorders, [link]
eating disorders, [link]
major depressive disorder, [link], [link]
Commitment, organizational, [link]
Community
attitudes toward mental illness, [link], [link]t
depression prevention interventions, [link]
mental health service reform initiatives, [link]
positive youth development programs, [link], [link]t, [link]t
therapeutic, for substance use disorders, [link]
Community assessment centers, for substance abuse treatment, [link]
Community factors, in anxiety disorders, [link]
Community-system approach, for substance abuse prevention, [link]
Comorbidity issues
in evidence-based mental health services, [link]
in substance use disorders, [link], [link], [link], [link]
Competencies, as outcome of positive youth development, [link], [link]
Compliance therapy, for schizophrenia, [link]
Comprehensive College Initiative (CCI), [link]t, [link]
Comprehensive Community Mental Health Services for Children and Families (CMHSC), [link]
Compulsive disorders, in drug addiction, [link], [link]f
Conditioning, classical
in anxiety disorders, [link]
in substance use disorders, [link]
Conduct disorder, comorbidity
alcohol use disorders, [link]
anxiety, [link]
bipolar disorder, [link]
suicidal behavior, [link]
Confidentiality
in drug screening programs, [link], [link]
in suicide screening programs, [link]
Consent for services, minor, [link]
Contact effects, in reducing stigma of mental illness, [link], [link]
Contagion
anxiety disorders and, [link]
suicidal behavior and, [link], [link]
Context factors, in implementation and dissemination of evidence-based mental health services, [link]
Contingency management incentive systems, for substance use disorders, [link]
Contingent negative variation (CNV), in schizophrenia, [link], [link]t, [link]
Control, perceived, in anxiety disorders, [link]
Coping and Support Training (CAST), [link]
The Coping Cat Workbook, [link]
Coping skills strategies, in anxiety disorders, [link]
Coping with Depression–Adolescent version, [link]
“coping with stress” adaptation of, [link]
Corticotropin-releasing factor, in stress response, [link]
Cortisol
in adolescence, [link]
and dopamine activity, [link]
in schizophrenia, [link]
Counseling
firearms, [link], [link]t
genetic, in schizophrenia, [link]
school-based, [link], [link]t, [link], [link], [link]t
Counselors Care (C-CARE), [link]
Crack cocaine, [link]. See also[link]
Credentialing process, substance abuse treatment, [link]
Criminal behavior, and anxiety disorders, [link]
Cross-National Collaborative Group study, [link], [link]t
Cultural factors. See also[link]
in access to mental health services, [link]
in alcohol use disorders, [link]
in depression, [link]
in eating disorders, [link]
in positive youth development, [link]
Culture, organizational, [link]
Cutting, school professional findings, [link], [link]t
Dade County, Florida, suicide prevention program, [link]
“Dealing with it” approach, [link]
Delivery systems. See[link]
Dependence disorders, chemical. See[link]
Deployment focused model for treatment development, [link]
Depression
antepartum, [link]
with atypical features, [link]
brain abnormalities associated with, [link], [link]
with catatonic features, [link]
chronic, [link], [link]
cognitive diathesis-stress model, [link]
comorbidity
anxiety disorders, [link], [link], [link], [link]
substance use disorder, [link], [link], [link]
double, [link]
genetics, [link], [link]t
geriatric, [link]
help-Seeking behavior for, perceived effectiveness, [link], [link]t
hypothalamic-pituitary-adrenal axis hyperactivity, [link]
interpersonal vulnerability, [link]
major
age of onset, [link]
cognitive vulnerability to, [link]
combination therapy, [link], [link]
community attitudes toward, [link], [link]t
comorbidity, [link]
alcohol use disorders, [link]
dysthymia, [link]
eating disorders, [link], [link], [link]
impact on treatment outcome, [link], [link], [link]
diagnosis, [link], [link]t
versus dysthymic disorder, [link], [link]t
epidemiology, [link], [link]
family environment and, [link], [link]
family history and, [link]
gender and, [link], [link]
interpersonal vulnerability, [link]
personality/temperament and, [link]
pharmacotherapy. See also[link]
in adolescents, [link], [link]t
in adults, [link]
augmentation therapy, [link], [link]
combination therapy, [link]
with psychotherapy, [link]
prepubertal, versus adolescent-onset, [link], [link]
prevention programs, [link]
future directions and recommendations, [link]
indicated, [link]
research agenda, [link]
selective, [link]
universal, [link]
psychosocial therapy
in adults, [link]
in children and adolescents, [link]
with pharmacotherapy, [link]
preventive, [link], [link]
pubertal status and, [link]
rates, [link], [link]f
recurrence, [link], [link]
relationship to schizophrenia, [link]
research agenda, [link]
risk factors, [link], [link], [link]
sequelae to, [link], [link]
stress and, [link], [link]
subtypes, [link]
treatment research agenda, [link]
maternal
and offspring depression, [link], [link], [link]
and response to cognitive-behavioral therapy, [link], [link]f, [link]
with melancholic features, [link]
parental, and offspring depression, [link], [link], [link], [link]
pharmacotherapy. See[link]
postpartum, [link], [link]
postpsychotic, [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
rates, [link], [link]f, [link]f
relapse prevention, [link]
schizophrenia and, [link], [link]
school professional findings, [link], [link]t
self-propagating nature, [link]
specific vulnerability hypothesis, [link]
stress and, [link]
subsyndromal
cognitive-behavioral therapy for, [link]
as risk factor for major depression, [link]
treatment-resistant, [link]
Detoxification, [link]
Development
brain, during adolescence, [link] [link], [link]f, [link]
youth
applications, [link]
ecological approach, [link]
positive. See[link]
problem-centered approach, [link]
Developmental assets, in positive youth development, [link]
Developmental group therapy, for suicidal youth, [link]t, [link]
Developmental milestones, in schizophrenia, premorbid abnormalities, [link], [link]f, [link]f, [link]
Dextroamphetamine dependence, [link]. See also[link]
Diagnostic and Statistical Manual for Primary Care (DSM-PC), eating disorders criteria, [link]
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria
alcohol abuse and dependence, [link]
anorexia nervosa, [link], [link]t, [link]
bulimia nervosa, [link], [link]t
eating disorders, [link], [link]t, [link]t
schizophrenia, [link]
substance use disorders, [link], [link], [link]f
Dialectical behavioral therapy
for suicidal adults, [link]
for suicidal youth, [link]t, [link]
Diathesis-stress model of depression, [link]
Dietary restraint, definition, [link]
Dieting. See also[link]
anorexia nervosa and, [link]
bulimia nervosa and, [link]
definition, [link]
eating disorders and, [link], [link]
professionally administered
effects on eating behavior, [link]
effects on psychological status, [link]
research with adults, [link]
youth-based program, [link], [link]
Disorder, harmful dysfunction account of, [link]
Disorganization, in schizophrenia, [link]
Disruptive behavior disorders, plus depression, [link], [link]
Disulfiram, for alcohol use disorders, [link]
Divaloproex
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
maintenance therapy, [link]
with lithium, for bipolar disorder, [link]
Dopamine
in alcohol use, [link]
cortisol and, [link]
in drug addiction, [link], [link], [link]
in schizophrenia, [link]
in smoking, [link]
Dorsal lateral prefrontal cortex, developmental changes, [link]
Dot Probe Attention Allocation Task, [link]
Double depression, [link]
Drug abuse. See[link]
Drug Abuse Resistance Education (DARE), [link]
Drug Abuse Warning Network (DAWN), [link]
Drug courts, juvenile, [link]
Drug dealing, school professional findings, [link], [link]t
Drug screening. See[link], [link]
DSM-IV diagnostic criteria. See[link]
Duloxetine, for major depressive disorder, [link]
Dysbindin, as schizophrenia susceptibility gene, [link]
Dysthymic disorder
plus major depressive disorder, [link]
versus major depressive disorder, [link], [link]t
secondary, [link]
Eating disorders, [link]. See also[link]; [link]
combination therapy, [link]
community attitudes toward, [link], [link]t
comorbidity, [link], [link]
diagnostic criteria, [link], [link]t, [link]t, [link]
diagnostic migration, [link], [link]
dieting and, [link], [link]
epidemiology, [link], [link]t, [link]t, [link]
ethnic differences, [link]
etiology, [link]
medical complications, [link], [link]t, [link]
not otherwise specified, [link], [link], [link]
obesity as risk factor for, [link], [link]
outcome, [link], [link]
pharmacotherapy, [link], [link], [link]
prevalence, [link], [link]t, [link]t
prevention programs, [link]
combined, [link]
in high-risk populations and settings, [link]
research agenda, [link]
targeted, [link]
universal, [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
psychosocial therapy, [link], [link], [link]
relapse prevention, [link], [link]
research agenda, [link]
risk factors, [link], [link]t, [link]
school professional findings, [link], [link]t
symptoms, [link]
treatment, [link]
guidelines, [link]
issues specific to adolescents, [link]
research agenda, [link]
weight restoration, [link]
Ecological approach to youth development, [link]
“Ecstasy” (MDMA) use
anxiety and, [link]
clinical aspects, [link]
evolution, [link]
liquid, [link]
Education. See[link]; [link]
Effectiveness, organizational requirements for, [link]
Electroencephalography
in anxiety disorders, [link]
in schizophrenia, [link]
Electrolyte abnormalities, in eating disorders, [link]t
Electrophysiology, in schizophrenia, [link]
Emergency department
adolescent use of, [link]
substance use identification, [link]
suicide prevention interventions, [link], [link]t
Emotion(s)
brain circuitry for, developmental shifts, [link]
expressed, reduction, family therapy for, [link]
positive, [link]
Emotional competence, as outcome of positive youth development, [link]
Emotional processing
in anxiety disorders, [link]
in schizophrenia, [link]
Emotional Stroop task, [link]
Endocrine changes. See[link]
Engagement, pursuit of, in positive psychology, [link]
Environmental factors
during adolescence, [link]
in anorexia nervosa, [link]
in anxiety disorders, [link]
in smoking, [link]
in substance use disorders, [link]
Epidemiologic Catchment Area Study, [link], [link]t
Escitalopram, for major depressive disorder, [link]
Estrogen
in schizophrenia, [link]
supplementation, in anorexia nervosa, [link]
Ethical issues, in anxiety disorders, [link]
Ethnicity. See[link]
Ethnocultural factors, in depression, [link]
Event-related potentials (ERPs)
advantages, [link]
in anxiety disorders, [link]
in schizophrenia
in children and adolescents, [link], [link]t
contingent negative variation (CNV), [link], [link]t, [link]
current research, [link]
gamma-band activity, [link]
late positive component (P300), [link], [link]t, [link]
mismatch negativity and postonset progression of abnormalities, [link]
P1/N1 asymmetry, [link]t, [link]
processing negativity (Np), [link]t, [link]
sensory gating, [link], [link]
Evidence-based mental health services, [link]
definition, [link]
national registry, [link]
organizational context findings, [link]
reform initiatives, [link]
research gaps
categorization of practices, [link]
comorbidity issues, [link]
diagnostic classification, [link]
implementation and dissemination, [link]
lab-to-clinic translatability, [link]
treatment development, [link]
summary and recommendations, [link]
system barriers, [link]
access, [link]
cultural, [link]
financing policies, [link]
fragmentation, [link]
lack of family-driven practices, [link]
regulatory practices, [link]
Evidence-based policies, [link]
Evidence-based practices
categorization, [link]
popularity, [link]
substance abuse treatment, [link]
Evidence-Based Practices Project (EBPP) for Suicide Prevention, [link]
Executive inhibitory circuitry defects, in substance use disorders, [link]
Exercise, weight-bearing, in anorexia nervosa, [link]
Exosystem, [link]
Exposure and ritual prevention (EX/RP), for obsessive-compulsive disorder, [link]t, [link], [link]
Exposure therapy, for anxiety disorders, [link], [link], [link]
Expressed emotions, reduction, family therapy for, [link]
Extracurricular activities, for positive youth development, [link]
Extrapyramidal side effects, in schizophrenia, [link]
Familial aggregation, in schizophrenia, [link]
Family-based interventions
in eating disorders, [link]
in major depressive disorder, [link]
in substance abuse, [link]
for suicidal youth, [link]t, [link]
Family-driven practices, lack of attention to, [link]
Family environment
anorexia nervosa and, [link]
anxiety disorders and, [link]
major depressive disorder and, [link], [link]
suicidal behavior and, [link], [link]
Family history
bipolar disorder and, [link]
major depressive disorder and, [link]
Family therapy
for anorexia nervosa, [link], [link]
attachment-based, for major depressive disorder, [link]
for bipolar disorder, [link]
functional, state-level implementation, [link]
for schizophrenia
in adolescents, [link]
in adults, [link]
for substance use disorders, [link]
for suicide attempters, [link]
Fat, body, fear of, as criterion for anorexia nervosa, [link]
Fear
versus anxiety, [link]
of body fat or weight gain, as criterion for anorexia nervosa, [link]
brain circuitry for, developmental shifts, [link]
stranger, absence of, schizophrenia and, [link]
Fear structures, in anxiety disorders
cognitive-behavioral therapy and, [link]
emotional processing theory and, [link]
Feeding problems, early, bulimia nervosa and, [link]
Females. See[link]
Financing
for evidence-based mental health services, [link]
for substance abuse services, [link], [link], [link]
for suicide prevention evaluation studies, [link]
Finding Hope and Help program, suicide prevention, [link]
Firearms
availability, suicide and, [link], [link], [link]
restriction programs, [link], [link]t
First (initial) onset, definition, [link] [link]
Flashback, [link]
Flow state
in positive psychology, [link]
in positive youth development, [link]
Fluid abnormalities, in eating disorders, [link]t
Flunitrazepam abuse, [link]
Fluoxetine
for bulimia nervosa, [link]
for generalized anxiety disorder, [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link]t, [link]
with substance use disorder, [link]
for obsessive-compulsive disorder, [link]
for panic disorder, [link]
for phobia, [link]
for post-traumatic stress disorder, [link]
for selective mutism, [link]t, [link]
for suicide attempters, [link]
Flupenthixol, for schizophrenia, [link]t
Fluphenazine, for schizophrenia, [link]t, [link]
Fluvoxamine
for major depressive disorder, [link]
for obsessive-compulsive disorder, [link]
for panic disorder, [link]
for separation anxiety disorder, [link]
for social anxiety disorder, [link]t, [link]
Focus on Families Program, [link]
Follow-back studies, in schizophrenia, [link], [link], [link]t
Forget Me, [link]
FRIENDS program, [link]
Frontal-temporal circuitry, in schizophrenia, [link]
Frontal white matter volume, developmental changes, [link]
Functional family therapy, state-level implementation, [link]
Future expectations, positive, as outcome of positive youth development, [link]
Gamma-band activity, in schizophrenia, [link]
Gammahydroxybutyrate (GHB), [link]
Gang affiliation, and anxiety disorders, [link]
Gastrointestinal abnormalities, in eating disorders, [link]t
Gatekeeper training, for suicide prevention, [link]t, [link]
Gateway theory of substance abuse, [link], [link]
Gender differences
anorexia nervosa, [link]
anxiety disorders, [link]
major depressive disorder, [link], [link]
substance abuse treatment, [link]
substance use, [link]
suicide, [link]
Gene expression, hormones and, [link]
Generalized anxiety disorder, [link]
comorbidity, [link], [link]t
description, [link]
genetics, [link], [link]t
signs and symptoms, [link]t
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Genes, susceptibility
in anorexia nervosa, [link]
in schizophrenia, [link]
and adolescence, [link]
identification, [link]
in substance use disorders, [link]
Genetic counseling, in schizophrenia, [link]
Genetics, [link]
anorexia nervosa, [link]
anxiety disorders, [link], [link]t, [link]
bipolar disorder, [link], [link]t
bulimia nervosa, [link]
depression, [link], [link]t
schizophrenia, [link], [link], [link]
substance use disorders, [link] [link], [link]
suicidal behavior, [link]
Genome scans
in schizophrenia, [link]
in substance use disorders, [link]
Georgia Home Boy, [link]
Geriatric depression, [link]
Glucocorticoids, in stress response, [link]
Glutamate, in drug addiction, [link]
Gonadal hormones, and adolescent behavior, [link] [link]
Gordon, Robert, [link] [link]
Gray matter volume
developmental changes, [link] [link], [link]f
in schizophrenia, [link], [link]
Great Ormond Street criteria for eating disorders, [link]
Great Smoky Mountain Study, comorbidity findings, [link]
Group therapy
for bipolar disorder, [link]
for suicidal youth, [link]t, [link]
Growth hormone, in major depressive disorder, [link]
Growth retardation, in anorexia nervosa, [link]
Guanfacine, for post-traumatic stress disorder, [link]
Guidance counselors, [link], [link]t, [link], [link], [link]t
Gymnastics, anorexia nervosa and, [link]
Hallucinogens, [link]
Haloperidol
with lithium, for bipolar disorder, [link]
for schizophrenia, [link]t, [link]t, [link]t
Happiness, “authentic,” in positive psychology, [link]
Harm avoidance, and vulnerability to depression, [link]
Harvard Twin study, [link]
Hawaii, reform initiatives on delivery of evidence-based practices, [link]
Headache, depression and, [link]
Health insurance
adolescent
call to action, [link]
lack of, [link], [link]
managed care
behavioral, [link]
“carve-outs” for mental health care, [link], [link]
public, policy shift to, [link]
Health weight regulation (HWR) model, for eating disorder prevention, [link]
Help-Seeking behavior
perceived effectiveness, [link], [link]t
role of stigma, [link], [link]t
Hematopoietic abnormalities, in eating disorders, [link]t
Heroin use
behavioral therapy, [link]
clinical aspects, [link], [link]t, [link]t
detoxification, [link]
genetics, [link]
medications for long-term treatment, [link]
withdrawal, [link], [link]t
Heschl gyrus, in schizophrenia, [link]
Heterocyclic antidepressants, for major depressive disorder, [link]
High-risk studies, in schizophrenia, [link], [link], [link], [link]t, [link]
Hippocampus
in anxiety disorders, [link]
developmental changes, [link]
Hispanic Americans
depression, [link]
female suicide attempters, emergency department interventions, [link], [link]t, [link]
substance use, [link]
suicide rate, [link]
Home and Away, [link]
Homosexuality, suicidal behavior and, [link]
Hopelessness, suicidal behavior and, [link]
Hormonal changes. See[link]
Hormone replacement therapy, in anorexia nervosa, [link]
Hospitalism, [link]
HPA (hypothalamic-pituitary-adrenal) axis. See[link]
HPG (hypothalamic-pituitary-gonadal) axis, [link]
Human potential, in positive psychology movement, [link]
Hyperactivity. See[link]
Hypokalemia, in bulimia nervosa, [link]
Hypomania, in bipolar disorder, [link]
Hyponatremia, in anorexia nervosa, [link]
Hypophosphatemia, in anorexia nervosa, [link], [link]
Hypothalamic-pituitary-adrenal (HPA) axis
activation in puberty, [link] [link]
in anxiety disorders, [link]
in mood disorders, [link]
in schizophrenia, [link]
in schizotypal personality disorder, [link]
Hypothalamic-pituitary-gonadal (HPG) axis, [link]
Iceland, depression prevention program, [link]
Identity, positive, [link]
I'm Still Here, [link]
Imaging studies. See[link]
Imipramine
for major depressive disorder, [link], [link]t
for panic disorder, [link]
for separation anxiety disorder, [link]
Immunology, in anxiety disorders, [link]
Impulse control disorder, in drug addiction, [link], [link]f
Impulsivity
bulimia nervosa and, [link]
suicidal behavior and, [link]
Indicated prevention programs, [link]
anxiety disorders, [link]
definition, [link] [link]
major depressive disorder, [link]
suicide, [link]
Infant, depression in, stress and, [link]
Infertility, in anorexia nervosa, [link]
Information processing, in schizophrenia, event-related indices, [link], [link]t
Inhalant abuse, [link]
Initial onset, definition, [link] [link]
Innovation, diffusion of, organizational context findings, [link]
Inpatient treatment
anorexia nervosa, [link]
bipolar disorder, [link]
substance use disorders, [link]
Institute of Medicine, report on prevention of mental disorders, [link] [link] [link], [link]
Insurance. See[link]
Intelligent quotient, in children of schizophrenic parents, [link], [link]f
International Classification of Diseases, Tenth Revision (ICD-10), [link]
Internet interventions/surveys
anxiety disorders, [link]
eating disorders, [link]
reducing stigma of mental illness, [link]
suicidal behavior, [link]t, [link], [link]
Interpersonal relationships
alcohol use disorders and, [link]
anorexia nervosa and, [link]
depression and, [link]
suicidal behavior and, [link]
Interpersonal skills, as outcome of positive youth development, [link]
Interpersonal student conflict, school professional findings, [link], [link]t
Interpersonal therapy
for bipolar disorder, with social rhythm therapy, [link]
for bulimia nervosa, [link], [link], [link]
for major depressive disorder
in adolescents, [link]
in adults, [link], [link]
for schizophrenia, [link]
Interpretative threat bias, in anxiety disorders, [link]
Interventions in adolescence. See also specific types, e.g., [link]
effectiveness, [link]
pharmacological. See[link]
positive. See[link]
preventive. See[link]
psychosocial. See[link]
settings, [link]
types, [link]
Interview
motivational, in substance use disorders, [link]
psychiatric, in schizophrenia, [link]
Ipecac abuse, in bulimia nervosa, [link]
Job satisfaction, [link]
Juvenile drug courts, [link]
Juvenile justice system, substance abuse services, [link], [link]
Kentucky
anti-marijuana campaign, [link]
reform initiatives on delivery of evidence-based practices, [link]
Ketamine, [link]
Lab-to-clinic translatability, of evidence-based mental health services, [link]
Labels, stigma and, [link]
Lamotrigine, for bipolar disorder, [link]
Language delay, in schizophrenia, premorbid abnormalities, [link], [link]f
Leadership, organizational, [link]
Learning theories, in anxiety disorders, [link]
Legal issues, in suicidal behavior, [link]
Life Goals Program, for bipolar disorder, [link]
Life satisfaction, in positive youth development, [link]
Life Skills Training Program, [link]
Life stress, early
hypothalamic-pituitary-adrenal axis hyperactivity, [link]
major depression and, [link], [link]
Linkage disequilibrium studies, in schizophrenia, [link]
Linkage studies
in schizophrenia, [link]
in substance use disorders, [link]
Lithium
for anorexia nervosa, [link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
with antipsychotics, [link]
with divaloproex, [link]
maintenance therapy, [link]
for major depressive disorder, [link]
for schizophrenia, [link]
for suicide attempters, [link]
Locker searches, [link]
Locus ceruleus, in anxiety disorders, [link], [link]
LSD (lysergic acid diethylamide), [link]
MacArthur Foundation Youth Mental Health Network, [link]
Macrosystem, [link]
Magnetic resonance imaging
brain volumetric, in schizophrenia, [link]
functional, in anxiety disorders, [link]
in mood disorders, [link]
morphometric, in anxiety disorders, [link]
Magnetic resonance spectroscopy, in anxiety disorders, [link]
Magnetoencephalography, in schizophrenia, [link]
Maintenance/interventions, definition, [link] [link]
Major depressive disorder. See[link]
Males. See[link]
Malnutrition
maternal, anorexia nervosa and, [link]
medical complications, [link], [link]t
Maltreatment, depression and, [link], [link]
Managed care
behavioral, [link]
“carve-outs” for mental health care, [link], [link]
Mania. See also[link]
age of onset, [link]
comorbidity
anxiety disorders, [link]
attention-deficit/hyperactivity disorder, [link]
conduct disorder, [link]
substance abuse, [link]
diagnostic criteria, [link]
mixed, [link]
Marijuana use
anxiety and, [link]
clinical aspects, [link]
in gateway theory, [link]
genetics, [link]
mass media prevention campaigns, [link], [link]
prevalence, [link]f
in schizophrenia, [link]
treatment, [link], [link], [link], [link]
withdrawal, [link]
Marital behavioral therapy, for major depressive disorder, [link]
Mass media
drug abuse prevention campaigns, [link]
misinformation about mental illness, [link]
for reducing stigma of mental illness, [link]
suicide coverage, [link]
Maternal depression
and offspring depression, [link], [link], [link]
and response to cognitive-behavioral therapy, [link], [link]f, [link]
Maternal-infant therapy, for depression, [link]
Maternal malnutrition, anorexia nervosa and, [link]
Maudsley method, in anorexia nervosa, [link]
MDMA. See[link]
Meaning, pursuit of, in positive psychology, [link]
Media. See[link]
Medicaid
behavioral managed care, [link]
expansion of mental health services, [link]
funding in schools, [link], [link]
Medical disorders, depression and, [link]
Melancholic features, depression with, [link]
Menarche, early, bulimia nervosa and, [link]
Mental health disorders, [link]. See also specific disorders, e.g.,[link]
call to action, [link]
drug treatment of depression, [link]
early detection and treatment as prevention strategy, [link]
future directions, [link]
insurance coverage, [link]
research needs, [link]
universal prevention, [link]
confidentiality issues, [link], [link], [link]
diagnostic classification, research gaps, [link]
failure to treat, consequences, [link]
insurance coverage, [link], [link], [link]
interventions
pharmacological. See[link]
positive. See[link]
preventive. See[link]
psychosocial. See[link]
school-based. See[link]
settings, [link]
types, [link]
misinformation about, [link]
in primary care setting. See[link]
stigma of, [link]
in community attitudes, [link], [link]t
consequences, [link]
factors contributing to, [link]
reducing, [link], [link]
role in help-Seeking behavior, [link], [link]t
suicidal behavior and, [link]
treatment, [link]
definition, [link] [link]
effectiveness, [link]
evidence-based. See[link]
impact of stigmatization, [link]
inadequacy of resources, [link], [link], [link], [link]
minor consent for, [link]
Mental Health Parity Act, [link]
Mental health professionals
physician collaboration with, [link]
referral to
primary care physician practices, [link], [link]t, [link], [link], [link]t, [link]
school practices, [link], [link], [link], [link]t
Mental health services
access to
cultural barriers, [link]
in schools, [link], [link], [link]t, [link]t
survey findings, [link], [link], [link]
system barriers, [link]
delivery systems. See[link]
evidence-based. See[link]
in primary care settings. See under[link]
school-based. See under[link]
settings, [link]
substance abuse–related, [link], [link]
Mescaline, [link]
Mesosystem, [link]
Methadone, for opioid addiction, [link], [link]
Methamphetamine dependence, [link]. See also[link]
Methodological Epidemiologic Catchment Area Study, [link], [link]t
Mexican Americans
access to mental health services, [link]
depression in, [link]
Michigan, reform initiatives on delivery of evidence-based practices, [link]
Microsystem, [link]
Minnesota Twelve-Step model, for substance use disorders, [link], [link]
Minor consent for services, [link]
Molecular genetic studies, in schizophrenia, [link]
Molindone, for schizophrenia, [link]t
Monitoring the Future (MTF) study, [link]
Monoamine oxidase inhibitors, for major depressive disorder, [link]
Mood disorders, [link]. See also[link]; [link]
age of onset, [link]
biology, [link]
comorbidity
alcohol use disorders, [link]
eating disorders, [link], [link]
epidemiology and definitions, [link]
relationship to schizophrenia, [link]
research agenda, [link]
in schizophrenia, [link]
seasonal, [link]
suicidal behavior and, [link]
trait vulnerability factor common to, [link]
treatment, [link]
Mood stabilizers, [link], [link]t. See also specific drugs, e.g.,[link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
combination therapy, [link]
for schizophrenia, [link]
Moral competence, as outcome of positive youth development, [link]
Motivational interview, in substance use disorders, [link]
Motor deficits, in schizophrenia, [link], [link], [link]f, [link]f, [link]t, [link], [link], [link]
Multidimensional Anxiety Scale for Children (MASC), [link]
Multidimensional family therapy, for substance use disorders, [link]
Multisystemic therapy, for substance use disorders, [link]
Mutism, selective, [link]
maintenance of gains, [link]
treatment, [link]t, [link], [link]t
Myelinization
in schizophrenia, [link], [link]
Naltrexone
for alcohol use disorders, [link]
for opioid addiction, [link]
Narcotic abuse. See[link]
National Alliance for Mental Illness, [link]
National Annenberg Risk Survey of Youth (NARSY), [link], [link]t
National Comorbidity Survey, [link]
bipolar disorder, [link]
depression, [link], [link]f
National Household Survey on Drug Use and Health (NHSDUH), [link]
National Institute of Mental Health Center for Prevention Research, [link]
National Registry of Effective Practices (NREP), [link]
National Youth Anti-Drug Media Campaign, [link]
Native Americans
substance use, [link]
suicide prevention programs, [link]
suicide rate, [link]
Nefazodone, for major depressive disorder
in adults, [link], [link]
in children and adolescents, [link], [link]t
Negative affectivity
bulimia nervosa and, [link]
and vulnerability to depression, [link]
Negative cognitions, and vulnerability to depression, [link]
Negative life events
anorexia nervosa and, [link]
social support and, [link]
suicidal behavior and, [link]
Negative self-talk, reduction, for anxiety disorders, [link]
Negative symptoms, in schizophrenia, [link]
Networks of care, interorganizational, for substance abuse treatment, [link]
Neuregulin 1, as schizophrenia susceptibility gene, [link]
Neuroanatomic studies, in schizophrenia, [link]
Neurobehavioral deficits, in schizophrenia, [link]
Neurobiology
anxiety disorders, [link], [link]
schizophrenia, [link], [link]
substance use disorders, [link]
Neurochemistry, anxiety disorders, [link]
Neuroendocrine changes
during adolescence, [link] [link]
child abuse and, [link]
in eating disorders, [link]t
in schizophrenia, [link]
Neurogenesis, postnatal, [link]
Neuroimaging
in anxiety disorders, [link]
in mood disorders, [link]
in schizophrenia, [link]
in substance use disorders, [link]
Neurologic signs, in schizophrenia, premorbid abnormalities, [link]t, [link], [link], [link]
Neuropsychological deficits, in children of schizophrenic parents, [link]
Neuroticism
as risk factor for psychopathology, [link]
and vulnerability to depression, [link]
Neurotransmitter systems. See also specific types, e.g.,[link]
in anxiety disorders, [link]
maturation, [link]
New York, reform initiatives on delivery of evidence-based practices, [link]
Nicotine receptors, smoking and, [link]
Nicotine-replacement therapy (NRT), [link]
Novelty, amygdala response to, [link]
Np (processing negativity), in schizophrenia, [link]t, [link]
Nurse, school, [link]t
Nurse practitioner, school-based, [link]t
Obesity
anorexia nervosa and, [link]
bulimia nervosa and, [link]
depression and, [link]
professionally administered weight loss programs for, [link]
as risk factor for eating disorders, [link], [link]
Obsessive-compulsive disorder
in children and adolescents, [link]
description, [link], [link]
plus eating disorders, [link], [link]
genetics, [link]t
PANDAS subgroup, [link], [link]
rating scale, [link]
signs and symptoms, [link]t
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
investigational, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Obstetrics-gynecology, and early detection and screening of anxiety disorders, [link]
OCD. See[link]
Ohio, reform initiatives on delivery of evidence-based practices, [link]
Olanzapine
for anorexia nervosa, [link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
for post-traumatic stress disorder, [link]
for schizophrenia, [link]t, [link]t, [link]t, [link]
Ondansetron, for bulimia nervosa, [link]
Onset
first (initial), definition, [link] [link]
risk of, versus risk of relapse, [link] [link]
Opioid abuse
behavioral therapy, [link]
clinical aspects, [link], [link]t, [link]t
detoxification, [link]
genetics, [link]
medications for long-term treatment, [link]
withdrawal, [link], [link]t
Opioid pain relievers, [link]t, [link]
Opioid system, alcohol abuse and, [link]
Oppositional disorder, plus anxiety, [link]
Organizational context, impact on service delivery, [link]
Organizations
climate, [link]
culture, [link]
effectiveness studies, [link]
leadership, [link]
readiness to change, [link]
structure, [link]
work attitudes, [link]
Osteopenia, in anorexia nervosa, [link], [link]
Outward Bound, [link], [link]t
Overanxious disorder. See[link]
Overweight children and adolescents, professionally administered weight loss programs for, [link]
P300 (late positive component), in schizophrenia, [link], [link]t, [link]
P1/N1 asymmetry, in schizophrenia, [link]t, [link]
Pacific Islanders, suicide rate, [link]
Pain relievers, opioid, [link]t, [link]
PANDAS, [link], [link], [link]
Panic attacks, neuroticism and, [link]
Panic control treatment, [link]t, [link], [link]
Panic disorder
in children and adolescents, [link]
comorbidity, [link], [link]t
bipolar disorder, [link]
bulimia nervosa, [link]
description, [link]
genetics, [link], [link]t
prevention, [link]
rating scales, [link]
signs and symptoms, [link]t
suicidal behavior and, [link]
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Parent(s)
depressed
and offspring depression, [link], [link], [link], [link]
and response to cognitive-behavioral therapy, [link], [link]f, [link]
firearms counseling programs, [link], [link]t
physician likelihood of discussing adolescent mental health problems with, [link], [link]t
substance use by, and offspring substance use, [link]
suicidal, and offspring suicide, [link]
Parent-child interaction
in anxiety disorders, [link]
in suicidal behavior, [link]
Parent-child interaction treatment (PCIT), state-level implementation, [link]
Parenting dimension
in alcohol use disorders, [link]
in anxiety disorders, [link]
in depression, [link]
Parity, mental health service, [link], [link]
Paroxetine
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link]t
for panic disorder, [link]
Partnership for a Drug-Free America, [link]
Patterson's developmental theory of substance abuse, [link]
PCP (phencyclidine), [link]
P50–early sensory gating endophenotype, in schizophrenia, [link], [link]
Peer relations, [link]
alcohol use disorders and, [link]
anxiety disorders and, [link]
in children of schizophrenic parents, [link], [link]
depression and, [link]
smoking and, [link]
Pemoline, for ADHD plus substance use disorder, [link]
Penn Resiliency Program, [link], [link]t
Perfectionism, bulimia nervosa and, [link]
Performance-limited social anxiety, [link]
Perinatal events, anorexia nervosa and, [link]
Personal Assessment and Crisis Evaluation (PACE) clinic, [link]
Personal Growth Class (PGC), [link]
Personality
anorexia nervosa and, [link]
bulimia nervosa and, [link]
in children of schizophrenic parents, [link]
genetic contributions, [link]
major depressive disorder and, [link]
smoking and, [link]
Personality disorder(s)
borderline, plus suicidal behavior, dialectical behavioral therapy for, [link]
cluster C, plus anorexia nervosa, [link]
schizotypal, [link], [link]
HPA axis in, [link]
movement abnormalities, [link]
Pessimistic attributional style
suicidal behavior and, [link]
and vulnerability to depression, [link]
Pharmacotherapy, [link]
for anorexia nervosa, [link], [link]
for anxiety disorders
with cognitive-behavioral therapy, [link]
rationale, [link]
recommendations, [link]t
research agenda, [link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
combination therapy, [link]
maintenance therapy, [link]
for bulimia nervosa, [link], [link]
for eating disorders, [link], [link], [link]
for generalized anxiety disorder, [link]t, [link], [link]
for major depressive disorder. See also[link]
in adolescents, [link], [link]t
in adults, [link]
augmentation therapy, [link]
combination therapy, [link]
with psychotherapy, [link]
for panic disorder, [link]t, [link], [link]
for phobia, [link]t, [link], [link]
for post-traumatic stress disorder, [link]t, [link], [link]
for schizophrenia, [link]
acute treatment, [link], [link]t
adjunctive agents, [link]
antipsychotic, [link], [link]t, [link], [link], [link]t
continuation and maintenance treatment, [link], [link]t
preventive, [link]
for selective mutism, [link]t, [link]
for separation anxiety disorder, [link]t, [link]
for social anxiety disorder, [link], [link]t, [link], [link]
for substance use disorders, [link]
for suicide attempters, [link]
Phencyclidine (PCP), [link]
Phenomics, [link]
Phobia
in children and adolescents, [link]
comorbidity, [link], [link]t
description, [link]
genetics, [link], [link]t
neuroticism and, [link]
signs and symptoms, [link]t
social. See[link]
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Physical abuse, suicidal behavior and, [link]
Physical activity modifications, in youth, [link]
Physician
primary care. See[link]
school-based, [link]t
Pimozide, for schizophrenia, [link]t
Pindolol, augmentation effect, in panic disorder, [link]
Pleasure, pursuit of, in positive psychology, [link]
Political interventions, for prevention of major depressive disorder, [link]
Popular culture, influences, [link]
Population stratification artifact, [link]
Positive emotions, [link], [link]
Positive identity, [link]
Positive prevention, [link], [link]
Positive psychology
definition, [link]
as goal of prevention programs, [link], [link]
integration with positive youth development field, [link]
as outcome target for anxiety prevention studies, [link]
principles, [link], [link]
Positive rehabilitation, [link]
Positive youth development, [link] [link]
for at-risk and troubled youth, [link]
description, [link]
future directions, [link]
gaps, [link]
glossary of terms, [link]
goals, [link], [link]
history, [link]
indicators of, [link]
institutions that enable, [link]
integration with positive psychology movement, [link]
natural history studies, [link]
overview, [link]
versus problem-centered approaches, [link]
programs, [link]
methodological issues, [link]
model, [link], [link]t
outcome studies, [link], [link]t
resiliency in, [link], [link]
for substance abuse prevention, [link], [link]
summary of current knowledge, [link]
working assumptions, [link]
Post-traumatic stress disorder
alcohol use disorders and, [link]
in children and adolescents, [link]
description, [link]
neuroticism and, [link]
prevention, [link], [link]
rating scales, [link]
signs and symptoms, [link]t
social support and, [link]
substance abuse and, [link]
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Postpartum depression, [link], [link]
Poverty
depression and, [link], [link]
school mental health services and, [link]
Prefrontal cortex, developmental changes, [link] [link]
Prefrontal-striatal circuitry, in schizophrenia, [link]
Pregnancy prevention programs, [link]t
Premature birth, anorexia nervosa and, [link]
President's New Freedom Commission on Mental Health (2003), [link], [link]
Prevalence
lifetime, [link]
point, [link]
Prevalence rate, [link]
Prevention
definitions, [link] [link]
early detection and treatment as strategy for, [link]
positive, [link], [link]
Prevention programs, [link]. See also specific disorders
anxiety disorders, [link]
eating disorders, [link]
goals, [link]
historical context, [link]
major depressive disorder, [link]
pregnancy, [link]t
schizophrenia, [link], [link]
stages, [link]
substance use disorders, [link], [link]t
suicide, [link]
types, [link]
Primary care setting
adolescent mental health problems in, [link] [link]
identification, [link], [link]t, [link], [link]t, [link]
physician knowledge, [link]
physician responsibilities, [link], [link]t
prevalence, [link], [link]t
priority during physical exams, [link], [link]t
referral practices, [link], [link]t, [link], [link], [link]t, [link]
screening, [link], [link], [link]t
stigma concerns, [link], [link]
treatment
collaborative relationships, [link]
perceived effectiveness, [link]
poor rate of, [link]
practices, [link], [link]t
resources, [link], [link]
adolescent substance use problems in, identification, [link], [link], [link]
physician survey
findings, [link], [link]t
methodology, [link]
sample characteristics, [link], [link]t
summary and conclusions, [link]
Primary prevention, [link]
Problem behavior theory of substance abuse, [link]
Problem-centered approach to youth development, [link]
Problem-solving therapy
for anxiety disorders, [link]
for major depressive disorder, [link]
for schizophrenia, [link]
for suicidal adults, [link]
for suicide attempters, [link]
Project STAR, [link]
Promoting Alternative Thinking Strategies program, [link]t
Promotion programs, [link]. See also[link]
Propanolol, for post-traumatic stress disorder, [link]
Prosocial involvement, as outcome of positive youth development, [link]
Prosocial norms, [link]
Prospective studies, in schizophrenia, [link], [link], [link], [link]t
Protective factors, definition, [link] [link]
Pruning process
in brain development, [link] [link], [link]f, [link]
in schizophrenia, [link], [link]
Psilocybin, [link]
Psychiatric interview, in schizophrenia, [link]
Psychiatric symptoms, in schizophrenia, premorbid abnormalities, [link], [link]t, [link]
Psychiatry, and early detection and screening of anxiety disorders, [link]
Psychobehavioral influences, in alcohol use disorders, [link]
Psychodynamic therapy, brief, for major depressive disorder, [link]
Psychoeducation. See also[link]
anxiety disorders, [link]
bipolar disorder, [link]
depression, [link]
eating disorders, [link]
for reducing stigma of mental illness, [link]
schizophrenia, [link], [link], [link]
substance abuse, [link]
suicide prevention, [link], [link]t, [link]t
Psychological characteristics, of positive youth development, [link]
Psychological climate, [link]
Psychological debriefing, [link]
Psychological factors, in smoking, [link]
Psychologist
referral to, primary care physician practices, [link]
school, [link], [link]t
Psychology, positive
integration with positive youth development field, [link]
principles, [link], [link]
Psychopharmacotherapy. See[link]
Psychosocial assessment, in schizophrenia, [link]
Psychosocial rehabilitation, [link]
Psychosocial therapy. See also specific types, e.g.,[link]
for anorexia nervosa, [link], [link]
for anxiety disorders
with pharmacotherapy, [link]
rationale, [link]
recommendations, [link]t
research agenda, [link]
for bipolar disorder, [link]
for bulimia nervosa, [link], [link]
for eating disorders, [link], [link], [link]
for generalized anxiety disorder, [link]t, [link], [link]
lab-to-clinic translatability, [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link]
with pharmacotherapy, [link]
preventive, [link], [link]
for obsessive-compulsive disorder, [link]t, [link], [link]
for panic disorder, [link]t, [link], [link]
for phobia, [link]t, [link]
for post-traumatic stress disorder, [link]t, [link], [link]
for schizophrenia, [link], [link]
for selective mutism, [link]t, [link]
for separation anxiety disorder, [link]t, [link], [link]t
for social anxiety disorder, [link], [link]t, [link]
for substance use disorders, [link]
for suicide attempters, [link], [link], [link]t
Psychotherapy. See also[link]
for major depressive disorder
cognitive-behavioral analysis system of, [link]
with pharmacotherapy, [link]
for suicidal behavior, [link], [link], [link]t
Psychoticism, in schizophrenia, [link]
Psychotropic drugs, [link]. See also specific type, e.g.,[link]
for eating disorders, [link]
Pubertal delay, in anorexia nervosa, [link]
Pubertal status
anorexia nervosa and, [link]
major depressive disorder and, [link]
Public health insurance, policy shift to, [link], [link]
Purging, in anorexia nervosa, [link], [link]t
Quantum Opportunities Program, [link]t
Queensland Early Intervention and Prevention of Anxiety Project, [link]t
Quetiapine, adjunctive, for bipolar disorder, [link]
Race/ethnicity
and access to mental health services, [link]
anorexia nervosa and, [link]
eating disorders and, [link]
substance use and, [link]
suicide and, [link]
Rapid Response (RR) emergency department intervention for suicidal adolescents, [link]t, [link]
Rating scales, anxiety, [link]
Reaction Index, [link]
Readiness to change, organizational, [link]
Reconnecting Youth (RY) Prevention Research Program, [link], [link], [link]
Refeeding, in anorexia nervosa, [link]
Referral practices
primary care physicians, [link], [link]t, [link], [link], [link]t, [link]
schools, [link], [link], [link], [link]t
Regulatory practices, in evidence-based mental health services, [link]
Rehabilitation, positive, [link]
Reimbursement, for substance abuse screening, [link]
Relaxation exercises, for anxiety disorders, [link]
Religious participation, for positive youth development, [link], [link]t
Research agenda, [link]
anxiety disorders, [link]
bipolar disorder, [link]
eating disorders, [link]
evidence-based mental health services, [link]
major depressive disorder, [link]
mood disorders, [link]
schizophrenia, [link]
substance use disorders, [link]
suicide prevention, [link]
Resiliency
in children of depressed parents, [link]
as goal of prevention programs, [link]
as outcome of positive youth development, [link], [link]
Respiratory system, in panic disorder, [link], [link]
Restrained eating, definition, [link]
Restricting subtype, of anorexia nervosa, [link], [link]t
Retrospective studies, in schizophrenia, [link], [link], [link]t
Revised Children's Manifest Anxiety Scale (RCMAS), [link]
Reward center dysregulation, [link], [link]
allostasis and, [link]
animal models, [link], [link]f, [link]f
imaging studies, [link]
pharmacotherapy for, [link]
Risk factors, definition, [link] [link]
Risk of onset, versus risk of relapse, [link] [link]
Risperidone
augmentation effect, in obsessive-compulsive disorder, [link]
for bipolar disorder
in adults, [link]
with lithium, [link]
for schizophrenia, [link]t, [link]t, [link]t, [link], [link]
Ritual prevention, for obsessive-compulsive disorder, [link]t, [link], [link]
Rogers, Everett, [link]
Rohypnol abuse, [link]
Roofies, [link]
Route-of-administration principle, addictiveness and, [link]
Sample size, for prevention studies, [link]
Schizophrenia, [link]
adolescent-onset, developmental precursors, [link]
age-at-onset, [link], [link], [link]f
brain circuitry in, [link]
frontal-temporal, [link]
implications for adolescence, [link]
prefrontal-striatal, [link]
brain developmental abnormalities and, [link], [link]
children at risk for, longitudinal studies, [link], [link], [link], [link]t, [link]
cognitive deficits, [link]
pharmacotherapy, [link]
comorbid syndromes, adjunctive treatments, [link]
defining, [link]
depression in, [link], [link]
diagnostic criteria, [link]
duration of untreated psychosis, outcome and, [link], [link]
early interventions
effectiveness, [link]
preventive strategies, [link]
early-onset, [link], [link]
educational interventions, [link], [link], [link]
electrophysiology, [link]
emotion-processing deficits, [link]
endophenotypes
definitions based on, [link]
gene-finding utility, [link]
molecular genetic studies, [link]
research findings, [link], [link]t, [link], [link]
etiology, [link]
event-related potential studies, [link], [link]t. See also[link]
first-episode
acute treatment, [link], [link]t, [link]
maintenance treatment, [link], [link]t
pharmacological management, [link], [link]t
psychotic relapses after, [link]
treatment of residual symptoms and comorbid syndromes, [link]
treatment-refractory, [link]
genetic counseling, [link]
genetic studies, [link], [link]
of association, [link]
and disease mechanisms, [link]
endophenotypes for, [link], [link]
of familial aggregation, [link]
future directions, [link]
of linkage, [link]
of psychiatric disorders transmitted, [link]
susceptibility genes, [link]
twin, [link]
magnetoencephalography, [link]
motor deficits, [link], [link], [link]f, [link]f, [link]t, [link], [link], [link]
natural history, [link]f
negative symptoms, [link], [link]
neuroanatomic studies, [link]
neurobehavioral deficits, [link]
neurobiology, [link], [link]
neuroendocrinology, [link]
outcome studies, [link]
overview, [link]
pathophysiology, in adolescence, [link]
pharmacotherapy, [link]
acute treatment, [link], [link]t
adjunctive agents, [link]
antipsychotics, [link], [link]t, [link], [link], [link]t
continuation and maintenance treatment, [link], [link]t
preventive, [link]
phenomenology, [link]
and genetics, [link]
and neural basis, [link]
research questions, [link]
positive symptoms, pharmacotherapy, [link]
premorbid abnormalities, [link]
age specificity, [link], [link]t, [link]
behavioral problems, [link], [link], [link]t, [link], [link], [link]
birth cohort studies, [link], [link], [link]t
cognitive deficits, [link], [link]f, [link], [link]f, [link], [link]
consistency of findings, [link], [link]t
developmental milestones, [link], [link]f, [link]f, [link]
follow-back studies, [link], [link], [link]t
high-risk studies, [link], [link], [link], [link]t, [link]
implications for preventive intervention, [link]
key precursors, [link]
language delay, [link], [link]f
motor deficits, [link], [link]f, [link]f, [link]t, [link], [link], [link]
neurologic signs, [link]t, [link], [link], [link]
psychiatric symptoms (nonschizophrenic), [link], [link]t, [link]
research needs, [link]
research strategies to identify, [link], [link]t
and vulnerability hypothesis, [link]
prevention efforts, [link], [link]
effectiveness, [link]
strategies, [link], [link]
targets for, [link]
primary care physician findings, [link], [link]t
prodromal symptoms, [link], [link]t, [link]f, [link]
acute treatment, [link], [link]t, [link]
characteristics, [link], [link]
early treatment projects, [link]
maintenance treatment, [link]
psychosocial assessment, [link]
psychosocial treatment, [link],